Publication NEWS (July 2018) - Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
Publication NEWS (July 2018) - Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline

"This review will focus on the most recent advances on CRISPR/Cas9 implementation in zebrafish and all their potential uses in biomedical research and drug discovery"

Download here

Zebrafish Services - Functional Genomics and Target Validation

Zebrafish Services - Functional Genomics and Target Validation

High-Throughput CRISPR-based Screening in Zebrafish

If you are involved in functional genomics or target validation and wish to benefit from recent advances in CRISPR technology without impacting your resources and timelines…

Why not outsourcing your gene editing work to a specialist team?

Our partner, ZeClinics, is the leading zebrafish company in Europe and experts in using CRISPR/Cas9* to do both simple and advanced genome editing in zebrafish. 

  • Single and double Knock-outs
  • Conditional Knock-outs
  • Short and large Knock-ins
  • Targeted gene mutation
  • Gene tagging

You can have your founder animals as soon as 3 months and can start screening for the relevant phenotype using one of the many phenotypic assays offered (see examples below).  

 

Phenotypic Assays - Overview

Neuroprotection

  • Locomotion characterisation
  • Motoneuron cluster confocal imaging

Cardioprotection

  • Heart beat frequency (Ventricle and Atrium)
  • Arrhythmia
  • QT prolongation (A/V ratio)
  • Fibrillation
  • Cardiac arrest
  • Ejection Fraction
  • Vein/Artery Blood Flow Velocity

Atherosclerosis

  • Whole body measurement of cholesterol levels
  • Image analysis of cholesterol vascular accumulation

Duchene Muscular Dystrophia

  • Locomotion characterization
  • Optical birefringence.
  • Genotyping
  • Immuno-histochemistry

Hearing Loss Assay

  • Phenotypical saccular macula analysis
  • Confocal microscopy functionality assessment
  • Sound response assay
  • Phenotypical scoring of mutants

Parkinson & Epilepsy behavioural assays

  • Locomotion characterization
  • Convulsion characterization
  • Thigmotaxis evaluation
  • Stimuli habituation (light/dark, sound and tapping responses)
  • Neuronal morphology confocal imaging

 

Click on the link to find out more about our this powerful Genome Editing Service Platform in Zebrafish. 

Request Quote/More Information  

 

*ZeClinics has the CRISPR/Cas9 license from the Broad Institute, MIT, Harvard University

Request Quote / Request More Information
This site uses the functionality that older versions of Internet Explorer does not support. You should therefore switch or upgrade your browser.